Jesus O. Navarro
Expertise in
5
conditions

Dr. Jesus O. Navarro

Nephrology
4710 N Habana Ave, Ste 300, 
Tampa, FL 
Offers Telehealth
Expertise in
5
conditions
4710 N Habana Ave, Ste 300, 
Tampa, FL 

Overview

Jesus Navarro is a Nephrologist practicing medicine in Tampa, Florida.

Dr. Navarro is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Acute Kidney Failure, End-Stage Renal Disease (ESRD), Nephrosclerosis, and Chronic Kidney Disease.

Dr. Navarro is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 7 clinical trials.

Graduate Institution

Facultad De Ciencias Medicas (San Francisco De Macoris, Dominican Republic)

Residency

New York Medical College - GME: Internal Medicine

Specialties

Nephrology

Licenses

Specialist in FL

Board Certifications

American Board Of Internal Medicine

Fellowships

University of Miami School of Medicine

Hospital Affiliations

BayCare Physician Partners
St. Joseph's Hospital
St. Joseph's Children's Hospital
St. Joseph's Women's Hospital
St. Joseph's Hospital - South

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

National Kidney Partners, LLC
4710 N Habana Ave, Ste 300, Tampa, FL 33617

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 1/2, Multicenter Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy
A Phase 1/2, Multicenter Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Drug
Study Drug: BION-1301
Study Phase: Phase 1/Phase 2
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
Enrollment Status: Active_not_recruiting
Publish Date: July 18, 2024
Intervention Type: Device, Other
Study Phase: Not Applicable
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients With Uncontrolled Gout Who Have Undergone Kidney Transplantation
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients With Uncontrolled Gout Who Have Undergone Kidney Transplantation
Enrollment Status: Completed
Publish Date: June 26, 2024
Intervention Type: Biological
Study Drug: Pegloticase
Study Phase: Phase 4
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients With Enteric Hyperoxaluria
A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients With Enteric Hyperoxaluria
Enrollment Status: Completed
Publish Date: March 08, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3
A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects With Autosomal Dominant Polycystic Kidney Disease
A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drug: Tesevatinib
Study Phase: Phase 2
View 6 Less Clinical Trials

1 Total Publications

Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment.
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment.
Journal: Clinical pharmacology and therapeutics
Published: March 15, 2022
Similar Doctors
Expertise in
17
conditions
Dr. Michael J. Brucculeri
Nephrology | Internal Medicine
Expertise in
17
conditions
Dr. Michael J. Brucculeri
Nephrology | Internal Medicine
Referral may be required

National Kidney Partners LLP

1055 S Fort Harrison Ave, 
Clearwater, FL 
 (29.0 miles away)
727-442-6245
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Brucculeri is an Internal Medicine specialist and a Nephrologist practicing medicine in Clearwater, Florida. Dr. Brucculeri is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, Acute Kidney Failure, Acute Tubular Necrosis, and Renovascular Hypertension. Dr. Brucculeri is board certified in AB Internal Medicine - Internal Medicine and AB Internal Medicine (Nephrology).

Expertise in
15
conditions
Dr. Dana A. Campbell
Nephrology
Expertise in
15
conditions
Dr. Dana A. Campbell
Nephrology
Referral may be required

D A Campbell MD PA

401 Corbett St, Ste 250, 
Clearwater, FL 
 (29.3 miles away)
727-734-2485
Languages Spoken:
English
See accepted insurances

Dana Campbell is a Nephrologist practicing medicine in Clearwater, Florida. Dr. Campbell is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Acute Kidney Failure, Necrosis, Acute Tubular Necrosis, and Renovascular Hypertension. Dr. Campbell is board certified in AB Internal Medicine (Nephrology).

Expertise in
10
conditions
Dr. Junaid Ahmed
Nephrology
Expertise in
10
conditions
Dr. Junaid Ahmed
Nephrology
Referral may be required

Florida Kidney Physicians LLC

409 Bayshore Blvd Fl 4, 
Tampa, FL 
 (34.0 miles away)
813-910-0030
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Junaid Ahmed is a Nephrologist practicing medicine in Tampa, Florida. Dr. Ahmed is highly rated in 10 conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Polycystic Kidney Disease, IgA Nephropathy, Simultaneous Pancreas Kidney Transplant, and Kidney Transplant. Dr. Ahmed is board certified in American Board Of Internal Medicine. Dr. Ahmed is currently accepting new patients.

Frequently Asked Questions about Dr. Jesus O. Navarro

How do I make an appointment with Dr. Jesus O. Navarro?

You can book an appointment with Dr. Jesus O. Navarro by calling their office at 813-873-1016. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jesus O. Navarro a top-rated expert for Acute Kidney Failure?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jesus O. Navarro is classified as an Distinguished expert for Acute Kidney Failure, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jesus O. Navarro specialize in?

While Dr. Jesus O. Navarro is a Nephrology, they have specific expertise in Acute Kidney Failure, End-Stage Renal Disease (ESRD), and Nephrosclerosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nephrology.

Does Dr. Jesus O. Navarro participate in research or clinical trials?

Yes. Dr. Jesus O. Navarro has published 1 articles and abstracts on conditions like Acute Kidney Failure. You can view a list of Dr. Jesus O. Navarro's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jesus O. Navarro accept my insurance?

Dr. Jesus O. Navarro accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 813-873-1016 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Navarro's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile